TITLE:
Tezacitabine and Oxaliplatin for the Treatment of Patients With Metastatic Colorectal Cancer

CONDITION:
Colorectal Neoplasms

INTERVENTION:
tezacitabine

SUMMARY:

      The primary purpose of this study is to determine the best dose of tezacitabine when
      combined with oxaliplatin in patients with metastatic colorectal cancer. This study will
      also evaluate tumor response to the combination of anti-cancer drugs.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        -  Patients with metastatic colorectal adenocarcinoma who have failed one prior course
             of chemotherapy.

          -  Patients must have at least one measurable tumor.

          -  Patients may not have received prior treatment with oxaliplatin.
      
